You are here

lovo-cel

Bluebird bio inks first Medicaid coverage agreement for sickle cell gene therapy, signing on with Michigan

Fierce Pharma

Mon, 03/11/24 - 11:33 am

sickle cell disease

13 Therapies Make Clarivate’s 2024 Drugs to Watch List

BioSpace

Wed, 01/10/24 - 06:30 pm

Tarpeyo/Kinpeygo

Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says

Fierce Pharma

Tue, 11/7/23 - 11:02 pm

Vertex Pharmaceuticals

sickle cell disease

Two Sickle Cell Disease Gene Therapies May Soon Be Approved By FDA

Forbes

Thu, 11/2/23 - 05:07 pm

sickle cell disease

Vertex Pharmaceutical

CRISPR Therapeutics

Bluebird’s Lovo-Cel Gene Therapy for SCD Will Not Face FDA Adcomm

BioSpace

Wed, 08/16/23 - 11:09 pm

sickle cell disease

9 Highly Anticipated FDA Decisions in Second Half of 2023

BioSpace

Fri, 06/30/23 - 11:52 am

Alzheimer's disease

SAGE Therapeutics

postpartum depression

major depressive disorder

non-small cell lung cancer

CRISPR Therapeutics

BrainStorm Cell Therapeutics

Bluebird, playing catch-up, gets decision date for sickle cell gene therapy

BioPharma Dive

Wed, 06/21/23 - 11:49 am

sickle cell disease

Bluebird Bio submits BLA for sickle cell disease gene therapy

Biopharma Reporter

Mon, 04/24/23 - 11:39 am

sickle cell disease

Bluebird to miss Q1 deadline for lovo-cel filing, shares sliced

Endpoints

Wed, 03/29/23 - 04:04 pm

sickle cell disease

FDA Lifts Partial Clinical Hold On Bluebird Bio's Sickle Cell Disease Studies

NASDAQ

Mon, 12/19/22 - 10:59 am

clinical trials

sickle cell disease

ASH: Despite partial clinical hold, bluebird's sickle cell gene therapy remains on track

Fierce Pharma

Sun, 12/11/22 - 01:34 pm

sickle cell disease

bluebird says future uncertain as delays to gene therapies bite

Pharmaforum

Sun, 03/6/22 - 11:18 pm

bluebird bio Announces Partial Clinical Hold for Patients Under 18 in Sickle Cell Gene Therapy Clinical Program

Yahoo Finance

Mon, 12/20/21 - 10:54 am

sickle cell disease

clinical trials